Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
暂无分享,去创建一个
T. Choueiri | G. De Velasco | B. Tran | A. Hansen | G. Bjarnason | B. Beuselinck | S. Pal | U. Vaishampayan | A. Lalani | D. Heng | F. Donskov | C. Gan | J. Wells | J. Lee | N. Dizman | N. Rathi | B. Szabados | M. Subasri | Shaan Dudani | Flora Yan | Aly-Khan A. Lalani | Mathushan Subasri